Tenaya Therapeutics Inc
TNYA
Get informed when a big investor buys or sells
+ FollowMarket Cap$145.01M
Close$
$0.59
32.2% downside
Current Fair Value
32.2% downsideOvervalued by 32.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $145.01 Million |
|---|---|
| Enterprise Value | $74.24 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.59 |
| Beta | 2.84 |
| Outstanding Shares | 152,971,259 |
Return
| Return on Equity | -78.17% |
|---|---|
| Return on Assets | -61.45% |
| Return on Invested Capital | -72.58% |
Valuation & Multiples
| P/E Ratio | -1.85 |
|---|---|
| PEG | 6.55 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 329.96 |
| Enterprise Value to EBIT | -0.86 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.14 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 13, 2026
EPS Estimate
$-0.09
Average shareholder expectationRevenue Estimate
$7.50 M
Average shareholder expectationNext Earnings Call
Expected Date
August 5, 2026
EPS Estimate
$-0.08
Average shareholder expectationRevenue Estimate
$10.00 M
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.2492▼ 4.13% |
|---|---|
| Total Calls | 275,700▼ 14.25% |
| Total Puts | 68,700▼ 26.45% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 35.50%▼ 6.46% |
|---|---|
| Total Invested | $37.51M▼ 23.07% |
| Investors Holding | 108▲ 4.00% |
ESG Score
No data
About Tenaya Therapeutics Inc
2,021 employees